癌症缓解症中的细胞外囊泡:解读致病作用和探索治疗视野
Yifeng Wang1,2, Shengguang Ding3
1Department of Thoracic Surgery, Affiliated Hospital 2 of Nantong University, Nantong First People's Hospital, Nantong, 226001, P.R. China.
Journal of translational medicine
|May 27, 2024
概括
细胞外囊泡 (EVs) 通过调解细胞间通信来驱动癌症缓解症 (CC). 针对这些EV,为这种衰弱的综合征提供了新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 癌症 (CC) 是一种复杂的综合征,影响50-80%的癌症患者,其特点是肌肉/脂肪损失,炎症和代谢中断.
- 细胞外囊泡 (EVs),包括外体和微囊泡,是瘤微环境中的细胞间通信的关键媒介,并与CC进展有关.
研究的目的:
- 审查目前关于细胞外囊泡 (EVs) 在癌症缓解症 (CC) 的发展和进展中的作用的文献.
- 探索EVs作为CC的诊断和预后生物标志物的潜力.
- 检查针对EVs的治疗策略,以管理CC.
主要方法:
- 综合性文献审查使用数据库,如PubMed,Scopus和科学网.
- 分析了研究的分析,重点是EV形成,释放,吸收和载荷,在癌症缓解症的背景下.
- 综合关于当前和新兴治疗干预措施的信息,针对CC中的EV.
主要成果:
- EVs通过转移蛋白质,脂质和核酸来促进CC中的细胞间通信,从而促进肌肉和脂肪的浪费.
- 电动汽车作为癌症缓解症的可靠诊断和预后生物标志物显示出希望.
- 针对EVs的治疗策略包括修改它们的释放/内容,使用它们用于药物输送,并抑制缓解症途径.
结论:
- 了解EVs在癌症缓解症中的多方面的作用,为疾病机制提供了关键的见解.
- 针对EVs为开发新型诊断工具和癌症缓解症的有效治疗干预提供了一个有希望的途径.
- 对EV介导通信的进一步研究对于改善癌症患者经历缓解症患者的治疗结果和生活质量至关重要.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Intralumenal Vesicles and Multivesicular Bodies
3.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Delivery Pathways to the Lysosome
6.3K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


